首頁 > 市場調查報告書 > 醫療設備

心血管設備

心臟再同步治療（CRT）市場規模、佔有率和成長分析（按產品、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1896754

心臟再同步治療（CRT）市場規模、佔有率和成長分析（按產品、應用、最終用戶和地區分類）－2026-2033年產業預測

Cardiac Resynchronization Therapy Market Size, Share, and Growth Analysis, By Product, By Application (Intraventricular Desynchrony, Interventricular Desynchrony), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，心臟再同步治療市場規模將達到 44.6 億美元，到 2025 年將達到 46.8 億美元，到 2033 年將達到 68.1 億美元，預測期（2026-2033 年）的複合年成長率為 4.8%。

心臟再同步治療市場分析顯示，心臟病和心臟病發作發生率的上升，以及醫療保健投資和支出的增加，是成長要素。技術進步和醫療設備的現代化將進一步促進市場擴張，尤其是在新興市場和老齡化社會。然而，不利的醫療改革、手術部位感染風險的增加以及器械的高敏感性等挑戰依然存在，這些挑戰可能會阻礙市場發展。相關人員在應對不斷變化的心臟再同步治療市場格局時，必須認真考慮這些因素，權衡機會與潛在限制，以最佳化患者療效並推動市場創新。

心臟再同步治療市場促進因素

心臟病及其相關危險因子的盛行率持續上升，顯著推高了對心臟再同步治療設備的需求。儘管預防和治療策略不斷取得進展，但猝死仍然是主要死因之一。心臟衰竭始終名列全球主要死因之列，凸顯了有效治療方法的迫切性。隨著心血管疾病患者數量的增加，心臟再同步治療市場預計將會擴大，因為改善患者預後和應對心臟疾病管理的重大挑戰至關重要。

心臟再同步治療市場的限制

由於產品召回，心臟再同步治療市場正面臨嚴峻挑戰，引發人們對某些設備可靠性的擔憂。主要製造商在發現可能影響設備性能的潛在安全問題後，被迫召回包括某些心律調節器和CRT-P在內的多種型號產品。這影響到先前已分銷的數千台設備，凸顯了技術故障帶來的風險。此類召回可能削弱消費者信心和病人安全，最終阻礙市場成長，並導致監管審查力度加大。這可能導致該領域新設備的監管更加嚴格，核准流程也更加漫長。

心臟再同步治療（CRT）市場趨勢

由於心臟衰竭盛行率不斷上升以及由此帶來的猝死風險增加，心臟再同步治療（CRT）市場正經歷顯著成長。 CRT-D（去心房顫動）結合了傳統心律調節器的功能和糾正危及生命的心律不整的能力，因其更優的治療效果而日益普及。智慧型手機連接、遠端監測和人性化設計等創新功能吸引了希望積極參與自身治療的患者。此外，電池續航力長和磁振造影相容性等特性也提升了CRT-D設備的吸引力，使其成為在不斷發展的循環系統醫療環境中管理心臟衰竭和改善患者預後的重要工具。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Medtronic plc（Ireland）
Boston Scientific Corporation（USA）
Abbott Laboratories（USA）
BIOTRONIK SE & Co. KG（Germany）
Lepu Medical Technology Co., Ltd.（China）
MicroPort Scientific Corporation（China）
LivaNova PLC（UK）
Medico SpA（Italy）
Nihon Kohden Corporation（Japan）
Koninklijke Philips NV（Netherlands）
Japan Lifeline Co., Ltd.（Japan）
Shree Pacetronix Ltd.（India）
Integer Holdings Corporation（OSCOR Inc.）（USA）
Osypka Medical GmbH（Germany）
St. Jude Medical, Inc.（acquired by Abbott）（USA）
Accellent Inc.（USA）
Cameron Health（acquired by Emerson Electric Co.）（USA）
Sorin Group（acquired by LivaNova）（Italy）
Guidant Corporation（acquired by Boston Scientific）（USA）
Cyberonics, Inc.（acquired by Abbott）（USA）

結論與建議

簡介目錄

Product Code: SQMIG35D2074

Cardiac Resynchronization Therapy Market size was valued at USD 4.46 Billion in 2024 and is poised to grow from USD 4.68 Billion in 2025 to USD 6.81 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026-2033).

Market insights into Cardiac Resynchronization Therapy indicate a significant growth trajectory influenced by rising incidence of heart disease and heart attacks, alongside increased healthcare investment and spending. Advancements in technology and the modernization of medical equipment further contribute to market expansion, particularly in emerging markets and among an aging population. However, challenges exist, including unfavorable healthcare reforms, the heightened risk of surgical site infections, and the high sensitivity of devices, which may impede market progress. These factors will require careful consideration as stakeholders navigate the evolving landscape of cardiac resynchronization therapy, balancing opportunities with potential constraints in order to optimize patient outcomes and drive market innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiac Resynchronization Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiac Resynchronization Therapy Market Segments Analysis

Global Cardiac Resynchronization Therapy Market is segmented by product, application, end user and region. Based on product, the market is segmented into cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers. Based on application, the market is segmented into intraventricular desynchrony, interventricular (V-V) desynchrony and atrioventricular (A-V) desynchrony. Based on end user, the market is segmented into hospitals & cardiac centers, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cardiac Resynchronization Therapy Market

The prevalence of heart diseases and related risk factors continues to rise, contributing significantly to the demand for cardiac resynchronization therapy devices. Sudden cardiac death remains a leading cause of mortality, even with ongoing advancements in prevention and treatment strategies. Heart failure consistently ranks among the top causes of death globally, highlighting the urgent need for effective therapies. As more individuals are affected by cardiovascular conditions, the market for cardiac resynchronization therapy is expected to expand, driven by the necessity to improve patient outcomes and address the critical challenges associated with managing heart-related disorders.

Restraints in the Cardiac Resynchronization Therapy Market

The Cardiac Resynchronization Therapy market is facing significant challenges due to product recalls, which have raised concerns about the reliability of certain devices. Notable manufacturers have had to withdraw various models, including specific pacemakers and CRT-Ps, after discovering potential safety issues that could compromise device performance. This has impacted thousands of devices that were previously distributed, highlighting the risks associated with technological malfunctions. Such recalls can undermine consumer confidence and patient safety, ultimately hindering market growth and increasing scrutiny from regulatory bodies, which may result in tighter regulations and longer approval processes for new devices in the sector.

Market Trends of the Cardiac Resynchronization Therapy Market

The Cardiac Resynchronization Therapy (CRT) market is experiencing significant growth driven by the increasing prevalence of heart failure and associated risks of sudden cardiac death. CRT-Defibrillators (CRT-D), which combine the functionalities of traditional pacemakers with the ability to correct life-threatening arrhythmias, are gaining popularity due to their enhanced therapeutic capabilities. Innovations such as smartphone connectivity, remote monitoring, and user-friendly designs are appealing to patients seeking greater engagement in their treatment. Additionally, features like extended battery life and MRI compatibility bolster the appeal of CRT-D devices, positioning them as essential tools in managing heart failure and improving patient outcomes in an evolving cardiovascular landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Cardiac Resynchronization Therapy Market Size by Product & CAGR (2026-2033)

Market Overview
Cardiac Resynchronization Therapy Defibrillators
Cardiac Resynchronization Therapy Pacemakers

Global Cardiac Resynchronization Therapy Market Size by Application & CAGR (2026-2033)

Market Overview
Intraventricular Desynchrony
Interventricular (V-V) Desynchrony
Atrioventricular (A-V) Desynchrony

Global Cardiac Resynchronization Therapy Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Cardiac Centers
Ambulatory Surgery Centers
Others

Global Cardiac Resynchronization Therapy Market Size & CAGR (2026-2033)

North America (Product, Application, End User)
- US
- Canada
Europe (Product, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medico S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Japan Lifeline Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shree Pacetronix Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integer Holdings Corporation (OSCOR Inc.) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka Medical GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
St. Jude Medical, Inc. (acquired by Abbott) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accellent Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cameron Health (acquired by Emerson Electric Co.) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sorin Group (acquired by LivaNova) (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guidant Corporation (acquired by Boston Scientific) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyberonics, Inc. (acquired by Abbott) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments